Bayesian Capital Management’s ViewRay, Inc. VRAY Stock Holding History

Bayesian Capital Management’s Portfolio VRAY Stock Details VRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-11,461	Closed	-$63K	–	960
2021 Q4	$63K	Buy	+11,461	New	+$69.8K	0.02%	350
2018 Q4	–	Sell	-15,700	Closed	-$147K	–	837
2018 Q3	$147K	Buy	+15,700	New	+$154K	0.02%	577

Other funds holding VRAY

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

HEC

Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return

Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bayesian Capital Management's VRAY Position: Q1 2022 in Review

Bayesian Capital Management sold out of ViewRay, Inc. (VRAY) in Q1 2022, closing a stake of 11,461 shares — an estimated $63K sold.

Bayesian Capital Management first reported a position in VRAY in Q3 2018 and held it in 2 quarters. The position peaked at $147K in Q3 2018. 173 funds tracked by Wall St. Rank hold VRAY as of Q1 2022.

Bayesian Capital Management reported no remaining ViewRay, Inc. position as of Q1 2022 after selling out during the quarter.
Bayesian Capital Management sold 11,461 ViewRay, Inc. shares in Q1 2022, an estimated $63K.
Bayesian Capital Management first reported a position in ViewRay, Inc. in Q3 2018 and held it in 2 quarters.
Bayesian Capital Management's ViewRay, Inc. position peaked at $147K in Q3 2018.
173 funds tracked by Wall St. Rank held ViewRay, Inc. as of Q1 2022.

Based on Bayesian Capital Management's 13F filing for Q1 2022, filed 16 May 2022.